Keywords

• Dapagliflozin
• Dapagliflozin powder
• 99% Dapagliflozin

Quick Details

• ProName: Dapagliflozin powder cas 461432-26-8
• CasNo: 461432-26-8
• Molecular Formula: C21H25ClO6
• Appearance: white
• Application: Artemisia annua is used as antimalaria...
• DeliveryTime: 7-10 days
• PackAge: drum
• Port: Shanghai/Wuhan
• ProductionCapacity: 1000 Kilogram/Month
• Purity: 99
• Storage: room
• LimitNum: 1 Kilogram

Superiority

Dapagliflozin  powder cas 461432-26-8 

Product Name:    Dapagliflozin
CAS:    461432-26-8
MF:    C21H25ClO6
MW:    408.88
EINECS:    639-683-0

Details

Dapagliflozin  powder cas 461432-26-8 

Product Name:    Dapagliflozin
CAS:    461432-26-8
MF:    C21H25ClO6
MW:    408.88
EINECS:    639-683-0 

Dapagliflozin It is also the first approved SGLT2 inhibitor for the treatment of type II diabetes, being an important option in the treatment of diabetes, and is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.
Dapagliflozin is   it for being used in the treatment of type II diabetes. Meanwhile, FDA requires the producers to conduct post-marketing research on drug-related risks.
The post-marketing trial requested by the FDA includes a cardiovascular outcome trial for assessing the cardiovascular risk for high-risk patients after treatment with dapagliflozin at baseline and a study to assess the risk of bladder cancer in recruited patients. Another study will assess the bladder tumor-promoting effect of this drug on rodent animals.